NCT Number: NCT00239213
Catechin Gargling for Influenza Infection
The purpose of this study is to clarify the preventive effects of catechin gargling on the influenza infection.
Looking for future studies?
Notify MeKey information
Conditions
Age range
20 year–65 year
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
Primary location
Seirei Hamamatsu General Hospital, Hamamatsu, Shizuoka, Japan
About this study
In-vitro experimental studies have revealed that tea catechin extracts induce preventive effects on influenza infection. However, few studies have been conducted on the effects of tea gargling on influenza infection, and the clinical evidence is unclear. Also there have been no studies reported on the gargling effects with tea catechin extracts on the prevention of influenza infection.
Who can participate
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- healthy volunteers
- aged 20 to 65 years old
- obtained written informed concent before participation
- inoculated with influenza vaccine before entering the study
Exclusion criteria
- other gargling except water during the study
- possessing tea allergy
Treatment and study plan
Primary outcomes
-
Incidence rates of influenza infection during the study
Secondary outcomes
-
severity of symptoms including complications and hospitalization
Sponsors and collaborators
Lead sponsor
University of Shizuoka
Other
Collaborators
- Seirei Hamamatsu General Hospital
- Shizuoka General Hospital
- White Cross Nursing Home
Registry information
Official study title
A Randomized Clinical Study of Catechin Gargling Effects on the Prevention of Influenza Infection
Important dates
- Study start
- 2005
- Study completion
- 2006
- First posted
- Oct 14, 2005
- Registry last updated
- Oct 31, 2006
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Efficacy and Safety of Molnupiravir in Healthy Participants Inoculated With Experimental Influenza Virus (MK-4482-019)
NCT05818124
Influenza Infection
London, London, City of, United Kingdom
View Trial DetailsLow Pathogenicity Avian H10N7 Influenza Virus in a Healthy Human Challenge Model
NCT05436444
Infections, Influenza Infection
Bethesda, Maryland, United States
View Trial DetailsDose, Safety, Tolerability and Immunogenicity of an Influenza H1 Stabilized Stem Ferritin Vaccine in Healthy Adults
NCT03814720
Hypersensitivity, Hypersensitivity, Immediate
Bethesda, Maryland, United States
View Trial DetailsA Phase 2, Double-blind Study to Evaluate Intranasal Trivalent Influenza Virus Vaccine in Healthy Adult
NCT03784885
Influenza Infection
Taipei, Taiwan
View Trial Details